EDTA,0,"CHRONIC RENAL FAILURE, AETIOLOGY UNCERTAIN"
EDTA,10,"GLOMERULONEPHRITIS, HISTOLOGICALLY NOT EXAMINED"
EDTA,11,SEVERE NEPHROTIC SYNDROME WITH FOCAL SCLEROSIS (PAEDIATRIC)
EDTA,12,IGA NEPHROPATHY PROVEN BY IMMUNOFLUORESCENCE
EDTA,13,"DENSE DEPOSIT DISEASE, MEMBRANO-PROLIF. GN TYPE II"
EDTA,14,MEMBRANOUS NEPHROPATHY
EDTA,15,MEMBRANO-PROLIFERATIVE GN TYPE I
EDTA,16,RAPIDLY PROGRESSIVE GN WITHOUT SYSTEMIC DISEASE (CRESCENTIC
EDTA,17,FOCAL SEGMENTAL GLOMERULOSCEROSIS WITH NEPHROTIC SYNDROME IN ADULTS
EDTA,19,"GLOMERULONEPHRITIS, HISTOLOGICALLY EXAMINED"
EDTA,199,UNAVAILABLE
EDTA,20,PYELO/INTERSTITIAL NEPHRITIS - CAUSE NOT SPECIFIED
EDTA,21,PYELO/INTERSTITIAL NEPHRITIS - WITH NEUROGENIC BLADDER
EDTA,22,PYELO/INTERSTITIAL NEPHRITIS - CONGEN. OBST. UROPATHY +/- REFLUX
EDTA,23,PYELO/INTERSTITIAL NEPHRITIS - ACQUIRED OBST. UROPATHY
EDTA,24,PYELO/INTERSTITIAL NEPHRITIS - VESICO-URETERIC REFLUX NO OBSTRUCTION
EDTA,25,PYELO/INTERSTITIAL NEPHRITIS - DUE TO UROLITHIASIS
EDTA,29,PYELO/INTERSTITIAL NEPHRITIS DUE TO OTHER CAUSE (PLEASE SPECIFY)
EDTA,30,TUBULO INTERSTITIAL NEPHRITIS (NOT PYELONEPHRITIS)
EDTA,31,NEPHROPATHY DUE TO ANALGESIC  DRUGS
EDTA,32,NEPHROPATHY  DUE TO CIS-PLATINUM
EDTA,33,NEPHROPATHY DUE TO CYCLOSPORIN A
EDTA,34,LEAD INDUCED NEPHROPATHY (INTERSTITIAL)
EDTA,39,NEPHROPATHY CAUSED BY OTHER SPECIFIC DRUG
EDTA,40,CYSTIC  KIDNEY  DISEASE - TYPE UNSPECIFIED
EDTA,41,POLYCYSTIC KIDNEYS - ADULT  TYPE (DOMINANT)
EDTA,42,POLYCYSTIC KIDNEYS - INFANTILE (RECESSIVE)
EDTA,43,MEDULLARY CYSTIC DISEASE - INCLUDING NEPHRONOPHTHISIS
EDTA,49,CYSTIC KIDNEY DISEASE - OTHER SPECIFIED TYPE
EDTA,50,HEREDITARY/FAMILIAL NEPHROPATHY - TYPE UNSPECIFIED
EDTA,51,HEREDITARY NEPHRITIS WITH NERVE  DEAFNESS  (ALPORT'S)
EDTA,52,CYSTINOSIS
EDTA,53,PRIMARY OXALOSIS
EDTA,54,FABRY'S  DISEASE
EDTA,59,HEREDITARY NEPHROPATHY - OTHER
EDTA,60,CONGENITAL RENAL  HYPOPLASIA - TYPE UNSPECIFIED
EDTA,61,OLIGOMEGANEPHRONIC HYPOPLASIA
EDTA,63,CONGENITAL RENAL DYSPLASIA +/- URINARY TRACT MALFORMATION
EDTA,66,SYNDROME OF AGENESIS OF ABDO. MUSCLES - PRUNE BELLY SYNDROME
EDTA,70,RENAL VASCULAR DISEASE - TYPE UNSPECIFIED
EDTA,71,RENAL VASCULAR DISEASE DUE  TO  MALIGNANT  HYPERTENSION
EDTA,72,RENAL VASCULAR DISEASE DUE  TO  HYPERTENSION
EDTA,73,RENAL VASCULAR DISEASE DUE TO  POLYARTERITIS
EDTA,74,WEGENER'S  GRANULOMATOSIS
EDTA,75,ISCHAEMIC RENAL DISEASE/CHOLESTEROL EMBOLISM
EDTA,76,GLOMERULONEPHRITIS RELATED TO LIVER CIRRHOSIS
EDTA,78,CRYOGLOBULINAEMIC GLOMERULONEPHRITIS
EDTA,79,RENAL VASCULAR DISEASE - CLASSIFIED (PLEASE SPECIFY)
EDTA,80,DIABETES TYPE 1 (INSULIN  DEPENDENT)
EDTA,81,DIABETES  TYPE 2 (NON-INSULIN DEPENDENT)
EDTA,82,MYELOMATOSIS
EDTA,83,AMYLOID
EDTA,84,SYSTEMIC LUPUS ERYTHEMATOSUS
EDTA,85,HENOCH-SCHONLEIN  PURPURA
EDTA,86,GOODPASTURES SYNDROME
EDTA,87,SCLERODERMA
EDTA,88,HAEMOLYTIC URAEMIC  SYNDROME
EDTA,89,MULTI-SYSTEM  DISEASE - TYPE UNSPECIFIED
EDTA,90,CORTICAL  OR TUBULAR  NECROSIS
EDTA,91,TUBERCULOSIS
EDTA,92,GOUT
EDTA,93,NEPHROCALCINOSIS / HYPERCALCAEMIC NEPHROPATHY
EDTA,94,BALKAN  NEPHROPATHY
EDTA,95,KIDNEY TUMOUR
EDTA,96,TRAUMATIC OR SURGICAL LOSS OF KIDNEY
EDTA,99,OTHER IDENTIFIED RENAL DISORDERS - PLEASE SPECIFY
EDTA2,1003,ADULT NEPHROTIC SYNDROME - NO HISTOLOGY
EDTA2,1019,NEPHROTIC SYNDROME OF CHILDHOOD - STEROID SENSITIVE - NO HISTOLOGY
EDTA2,1026,CONGENITAL NEPHROTIC SYNDROME (CNS) - NO HISTOLOGY
EDTA2,1035,CONGENITAL NEPHROTIC SYNDROME (CNS) - FINNISH TYPE - NO HISTOLOGY
EDTA2,1042,CONGENITAL NEPHROTIC SYNDROME (CNS) - FINNISH TYPE - HISTOLOGICALLY PROVEN
EDTA2,1057,CONGENITAL NEPHROTIC SYNDROME (CNS) - DIFFUSE MESANGIAL SCLEROSIS
EDTA2,1061,CONGENITAL NEPHROTIC SYNDROME (CNS) - FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
EDTA2,1074,DENYS-DRASH SYNDROME
EDTA2,1088,CONGENITAL NEPHROTIC SYNDROME (CNS) - CONGENITAL INFECTION
EDTA2,1090,MINIMAL CHANGE NEPHROPATHY - NO HISTOLOGY
EDTA2,1100,MINIMAL CHANGE NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,1116,IGA NEPHROPATHY - NO HISTOLOGY
EDTA2,1128,IGA NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,1137,FAMILIAL IGA NEPHROPATHY - NO HISTOLOGY
EDTA2,1144,FAMILIAL IGA NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,1159,IGA NEPHROPATHY SECONDARY TO LIVER CIRRHOSIS - NO HISTOLOGY
EDTA2,1163,IGA NEPHROPATHY SECONDARY TO LIVER CIRRHOSIS - HISTOLOGICALLY PROVEN
EDTA2,1171,IGM - ASSOCIATED NEPHROPATHY
EDTA2,1185,MEMBRANOUS NEPHROPATHY - IDIOPATHIC
EDTA2,1192,MEMBRANOUS NEPHROPATHY - MALIGNANCY ASSOCIATED
EDTA2,1205,MEMBRANOUS NEPHROPATHY - DRUG INDUCED
EDTA2,1214,MEMBRANOUS NEPHROPATHY - INFECTION ASSOCIATED
EDTA2,1222,MESANGIOCAPILLARY GLOMERULONEPHRITIS TYPE 1
EDTA2,1233,MESANGIOCAPILLARY GLOMERULONEPHRITIS TYPE 2 (DENSE DEPOSIT DISEASE)
EDTA2,1246,MESANGIOCAPILLARY GLOMERULONEPHRITIS TYPE 3
EDTA2,1251,IDIOPATHIC RAPIDLY PROGRESSIVE (CRESCENTIC) GLOMERULONEPHRITIS
EDTA2,1267,PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
EDTA2,1279,FAMILIAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) - AUTOSOMAL RECESSIVE - NO HISTOLOGY
EDTA2,1280,FAMILIAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) - AUTOSOMAL RECESSIVE - HISTOLOGICALLY PROVEN
EDTA2,1298,FAMILIAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) - AUTOSOMAL DOMINANT - NO HISTOLOGY
EDTA2,1308,FAMILIAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) - AUTOSOMAL DOMINANT - HISTOLOGICALLY PROVEN
EDTA2,1312,FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) SECONDARY TO OBESITY - NO HISTOLOGY
EDTA2,1320,FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) SECONDARY TO OBESITY - HISTOLOGICALLY PROVEN
EDTA2,1331,DIFFUSE ENDOCAPILLARY GLOMERULONEPHRITIS
EDTA2,1349,MESANGIAL PROLIFERATIVE GLOMERULONEPHRITIS
EDTA2,1354,FOCAL AND SEGMENTAL PROLIFERATIVE GLOMERULONEPHRITIS
EDTA2,1365,GLOMERULONEPHRITIS - SECONDARY TO OTHER SYSTEMIC DISEASE
EDTA2,1377,GLOMERULONEPHRITIS - HISTOLOGICALLY INDETERMINATE
EDTA2,1383,SYSTEMIC VASCULITIS - ANCA NEGATIVE - HISTOLOGICALLY PROVEN
EDTA2,1396,SYSTEMIC VASCULITIS - ANCA POSITIVE - NO HISTOLOGY
EDTA2,1401,GRANULOMATOSIS WITH POLYANGIITIS - NO HISTOLOGY
EDTA2,1417,GRANULOMATOSIS WITH POLYANGIITIS - HISTOLOGICALLY PROVEN
EDTA2,1429,MICROSCOPIC POLYANGIITIS - HISTOLOGICALLY PROVEN
EDTA2,1438,CHURG-STRAUSS SYNDROME - NO HISTOLOGY
EDTA2,1440,CHURG-STRAUSS SYNDROME - HISTOLOGICALLY PROVEN
EDTA2,1455,POLYARTERITIS NODOSA
EDTA2,1464,ANTI-GLOMERULAR BASEMENT MEMBRANE (GBM) DISEASE / GOODPASTURE'S SYNDROME - NO HISTOLOGY
EDTA2,1472,ANTI-GLOMERULAR BASEMENT MEMBRANE (GBM) DISEASE / GOODPASTURE'S SYNDROME - HISTOLOGICALLY PROVEN
EDTA2,1486,SYSTEMIC LUPUS ERYTHEMATOSUS / NEPHRITIS - NO HISTOLOGY
EDTA2,1493,SYSTEMIC LUPUS ERYTHEMATOSUS / NEPHRITIS - HISTOLOGICALLY PROVEN
EDTA2,1504,HENOCH-SCHONLEIN PURPURA / NEPHRITIS - NO HISTOLOGY
EDTA2,1515,HENOCH-SCHONLEIN PURPURA / NEPHRITIS - HISTOLOGICALLY PROVEN
EDTA2,1527,RENAL SCLERODERMA / SYSTEMIC SCLEROSIS - NO HISTOLOGY
EDTA2,1536,RENAL SCLERODERMA / SYSTEMIC SCLEROSIS - HISTOLOGICALLY PROVEN
EDTA2,1543,ESSENTIAL MIXED CRYOGLOBULINAEMIA - NO HISTOLOGY
EDTA2,1558,ESSENTIAL MIXED CRYOGLOBULINAEMIA - HISTOLOGICALLY PROVEN
EDTA2,1562,CRYOGLOBULINAEMIA SECONDARY TO HEPATITIS C - NO HISTOLOGY
EDTA2,1570,CRYOGLOBULINAEMIA SECONDARY TO HEPATITIS C - HISTOLOGICALLY PROVEN
EDTA2,1589,CRYOGLOBULINAEMIA SECONDARY TO SYSTEMIC DISEASE - NO HISTOLOGY
EDTA2,1591,CRYOGLOBULINAEMIA SECONDARY TO SYSTEMIC DISEASE - HISTOLOGICALLY PROVEN
EDTA2,1602,PRIMARY REFLUX NEPHROPATHY - SPORADIC
EDTA2,1618,FAMILIAL REFLUX NEPHROPATHY
EDTA2,1625,CONGENITAL DYSPLASIA / HYPOPLASIA
EDTA2,1639,MULTICYSTIC DYSPLASTIC KIDNEYS
EDTA2,1641,DYSPLASIA DUE TO FETAL ACE-INHIBITOR EXPOSURE
EDTA2,1656,GLOMERULOCYSTIC DISEASE
EDTA2,1660,CONGENITAL PELVI-URETERIC JUNCTION OBSTRUCTION
EDTA2,1673,CONGENITAL VESICO-URETERIC JUNCTION OBSTRUCTION
EDTA2,1687,POSTERIOR URETHRAL VALVES
EDTA2,1694,SYNDROME OF AGENESIS OF ABDOMINAL MUSCLES - PRUNE BELLY SYNDROME
EDTA2,1706,CONGENITAL NEUROGENIC BLADDER
EDTA2,1710,BLADDER EXSTROPHY
EDTA2,1723,MEGACYSTIS-MEGAURETER
EDTA2,1734,OLIGOMEGANEPHRONIA
EDTA2,1747,RENAL PAPILLARY NECROSIS - CAUSE UNKNOWN
EDTA2,1752,ACQUIRED OBSTRUCTIVE UROPATHY / NEPHROPATHY
EDTA2,1768,ACQUIRED OBSTRUCTIVE NEPHROPATHY DUE TO NEUROGENIC BLADDER
EDTA2,1775,OBSTRUCTIVE NEPHROPATHY DUE TO PROSTATIC HYPERTROPHY
EDTA2,1781,OBSTRUCTIVE NEPHROPATHY DUE TO PROSTATE CANCER
EDTA2,1799,OBSTRUCTIVE NEPHROPATHY DUE TO BLADDER CANCER
EDTA2,1809,OBSTRUCTIVE NEPHROPATHY DUE TO OTHER MALIGNANCIES
EDTA2,1813,IDIOPATHIC RETROPERITONEAL FIBROSIS
EDTA2,1821,RETROPERITONEAL FIBROSIS SECONDARY TO MALIGNANCIES
EDTA2,1832,CALCULUS NEPHROPATHY / UROLITHIASIS
EDTA2,1845,CALCIUM OXALATE UROLITHIASIS
EDTA2,1850,ENTERIC HYPEROXALURIA
EDTA2,1866,MAGNESIUM AMMONIUM PHOSPHATE (STRUVITE) UROLITHIASIS
EDTA2,1878,URIC ACID UROLITHIASIS
EDTA2,1884,TUBULOINTERSTITIAL NEPHRITIS - NO HISTOLOGY
EDTA2,1897,TUBULOINTERSTITIAL NEPHRITIS - HISTOLOGICALLY PROVEN
EDTA2,1907,FAMILIAL INTERSTITIAL NEPHROPATHY - NO HISTOLOGY
EDTA2,1911,FAMILIAL INTERSTITIAL NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,1924,TUBULOINTERSTITIAL NEPHRITIS ASSOCIATED WITH AUTOIMMUNE DISEASE - NO HISTOLOGY
EDTA2,1930,TUBULOINTERSTITIAL NEPHRITIS ASSOCIATED WITH AUTOIMMUNE DISEASE - HISTOLOGICALLY PROVEN
EDTA2,1948,TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS (TINU) - NO HISTOLOGY
EDTA2,1953,TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS (TINU) - HISTOLOGICALLY PROVEN
EDTA2,1969,RENAL SARCOIDOSIS - NO HISTOLOGY
EDTA2,1976,RENAL SARCOIDOSIS - HISTOLOGICALLY PROVEN
EDTA2,1982,ARISTOLOCHIC ACID NEPHROPATHY (BALKAN / CHINESE HERB / ENDEMIC NEPHROPATHY) - NO HISTOLOGY
EDTA2,1995,ARISTOLOCHIC ACID NEPHROPATHY (BALKAN / CHINESE HERB / ENDEMIC NEPHROPATHY) - HISTOLOGICALLY PROVEN
EDTA2,2005,DRUG-INDUCED TUBULOINTERSTITIAL NEPHRITIS  - NO HISTOLOGY
EDTA2,2014,DRUG-INDUCED TUBULOINTERSTITIAL NEPHRITIS - HISTOLOGICALLY PROVEN
EDTA2,2022,NEPHROPATHY DUE TO ANALGESIC DRUGS - NO HISTOLOGY
EDTA2,2033,NEPHROPATHY DUE TO ANALGESIC DRUGS - HISTOLOGICALLY PROVEN
EDTA2,2046,NEPHROPATHY DUE TO CICLOSPORIN - NO HISTOLOGY
EDTA2,2051,NEPHROPATHY DUE TO CICLOSPORIN - HISTOLOGICALLY PROVEN
EDTA2,2067,NEPHROPATHY DUE TO TACROLIMUS - NO HISTOLOGY
EDTA2,2079,NEPHROPATHY DUE TO TACROLIMUS - HISTOLOGICALLY PROVEN
EDTA2,2080,NEPHROPATHY DUE TO AMINOGLYCOSIDES - NO HISTOLOGY
EDTA2,2098,NEPHROPATHY DUE TO AMINOGLYCOSIDES - HISTOLOGICALLY PROVEN
EDTA2,2108,NEPHROPATHY DUE TO AMPHOTERICIN - NO HISTOLOGY
EDTA2,2112,NEPHROPATHY DUE TO AMPHOTERICIN - HISTOLOGICALLY PROVEN
EDTA2,2120,NEPHROPATHY DUE TO CISPLATIN - NO HISTOLOGY
EDTA2,2131,NEPHROPATHY DUE TO CISPLATIN - HISTOLOGICALLY PROVEN
EDTA2,2149,NEPHROPATHY DUE TO LITHIUM - NO HISTOLOGY
EDTA2,2154,NEPHROPATHY DUE TO LITHIUM - HISTOLOGICALLY PROVEN
EDTA2,2165,LEAD INDUCED NEPHROPATHY - NO HISTOLOGY
EDTA2,2177,LEAD INDUCED NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,2183,ACUTE URATE NEPHROPATHY - NO HISTOLOGY
EDTA2,2196,ACUTE URATE NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,2203,CHRONIC URATE NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,2219,RADIATION NEPHRITIS
EDTA2,2226,RENAL / PERINEPHRIC ABSCESS
EDTA2,2235,RENAL TUBERCULOSIS
EDTA2,2242,LEPTOSPIROSIS
EDTA2,2257,HANTAVIRUS NEPHROPATHY
EDTA2,2261,XANTHOGRANULOMATOUS PYELONEPHRITIS
EDTA2,2274,NEPHROPATHY RELATED TO HIV - NO HISTOLOGY
EDTA2,2288,NEPHROPATHY RELATED TO HIV - HISTOLOGICALLY PROVEN
EDTA2,2290,SCHISTOSOMIASIS
EDTA2,2300,OTHER SPECIFIC INFECTION
EDTA2,2316,DIABETIC NEPHROPATHY IN TYPE I DIABETES - NO HISTOLOGY
EDTA2,2328,DIABETIC NEPHROPATHY IN TYPE I DIABETES - HISTOLOGICALLY PROVEN
EDTA2,2337,DIABETIC NEPHROPATHY IN TYPE II DIABETES - NO HISTOLOGY
EDTA2,2344,DIABETIC NEPHROPATHY IN TYPE II DIABETES - HISTOLOGICALLY PROVEN
EDTA2,2359,CHRONIC HYPERTENSIVE NEPHROPATHY - NO HISTOLOGY
EDTA2,2363,CHRONIC HYPERTENSIVE NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,2371,MALIGNANT HYPERTENSIVE NEPHROPATHY / ACCELERATED HYPERTENSIVE NEPHROPATHY - NO HISTOLOGY
EDTA2,2385,MALIGNANT HYPERTENSIVE NEPHROPATHY / ACCELERATED HYPERTENSIVE NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,2392,AGEING KIDNEY - NO HISTOLOGY
EDTA2,2407,ISCHAEMIC NEPHROPATHY - NO HISTOLOGY
EDTA2,2411,ISCHAEMIC NEPHROPATHY / MICROVASCULAR DISEASE - HISTOLOGICALLY PROVEN
EDTA2,2424,RENAL ARTERY STENOSIS
EDTA2,2430,ATHEROEMBOLIC RENAL DISEASE - NO HISTOLOGY
EDTA2,2448,ATHEROEMBOLIC RENAL DISEASE - HISTOLOGICALLY PROVEN
EDTA2,2453,FIBROMUSCULAR DYSPLASIA OF RENAL ARTERY
EDTA2,2469,RENAL ARTERIAL THROMBOSIS / OCCLUSION
EDTA2,2476,RENAL VEIN THROMBOSIS
EDTA2,2482,CARDIORENAL SYNDROME
EDTA2,2495,HEPATORENAL SYNDROME
EDTA2,2509,RENAL AMYLOIDOSIS
EDTA2,2513,AA AMYLOID SECONDARY TO CHRONIC INFLAMMATION
EDTA2,2521,AL AMYLOID SECONDARY TO PLASMA CELL DYSCRASIA
EDTA2,2532,FAMILIAL AMYLOID SECONDARY TO PROTEIN MUTATIONS - NO HISTOLOGY
EDTA2,2545,FAMILIAL AMYLOID SECONDARY TO PROTEIN MUTATIONS - HISTOLOGICALLY PROVEN
EDTA2,2550,FAMILIAL AA AMYLOID SECONDARY TO FAMILIAL MEDITERRANEAN FEVER / TRAPS (HIBERNIAN FEVER) - NO HISTOLOGY
EDTA2,2566,FAMILIAL AA AMYLOID SECONDARY TO FAMILIAL MEDITERRANEAN FEVER / TRAPS (HIBERNIAN FEVER) - HISTOLOGICALLY PROVEN
EDTA2,2578,MYELOMA KIDNEY - NO HISTOLOGY
EDTA2,2584,MYELOMA CAST NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,2597,LIGHT CHAIN DEPOSITION DISEASE
EDTA2,2606,IMMUNOTACTOID / FIBRILLARY NEPHROPATHY
EDTA2,2610,HAEMOLYTIC URAEMIC SYNDROME (HUS) - DIARRHOEA ASSOCIATED
EDTA2,2623,ATYPICAL HAEMOLYTIC URAEMIC SYNDROME (HUS) - DIARRHOEA NEGATIVE
EDTA2,2634,THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
EDTA2,2647,HAEMOLYTIC URAEMIC SYNDROME (HUS) SECONDARY TO SYSTEMIC DISEASE
EDTA2,2652,CONGENITAL HAEMOLYTIC URAEMIC SYNDROME (HUS)
EDTA2,2668,FAMILIAL HAEMOLYTIC URAEMIC SYNDROME (HUS)
EDTA2,2675,FAMILIAL THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
EDTA2,2681,NEPHROPATHY DUE TO PRE-ECLAMPSIA / ECLAMPSIA
EDTA2,2699,SICKLE CELL NEPHROPATHY - NO HISTOLOGY
EDTA2,2702,SICKLE CELL NEPHROPATHY - HISTOLOGICALLY PROVEN
EDTA2,2718,AUTOSOMAL DOMINANT (AD) POLYCYSTIC KIDNEY DISEASE
EDTA2,2725,AUTOSOMAL DOMINANT (AD) POLYCYSTIC KIDNEY DISEASE TYPE I
EDTA2,2739,AUTOSOMAL DOMINANT (AD) POLYCYSTIC KIDNEY DISEASE TYPE II
EDTA2,2741,AUTOSOMAL RECESSIVE (AR) POLYCYSTIC KIDNEY DISEASE
EDTA2,2756,ALPORT SYNDROME - NO HISTOLOGY
EDTA2,2760,ALPORT SYNDROME - HISTOLOGICALLY PROVEN
EDTA2,2773,BENIGN FAMILIAL HAEMATURIA
EDTA2,2787,THIN BASEMENT MEMBRANE DISEASE
EDTA2,2794,CYSTIC KIDNEY DISEASE
EDTA2,2804,MEDULLARY CYSTIC KIDNEY DISEASE TYPE I
EDTA2,2815,MEDULLARY CYSTIC KIDNEY DISEASE TYPE II
EDTA2,2827,UROMODULIN-ASSOCIATED NEPHROPATHY (FAMILIAL JUVENILE HYPERURICAEMIC NEPHROPATHY)
EDTA2,2836,NEPHRONOPHTHISIS
EDTA2,2843,NEPHRONOPHTHISIS - TYPE 1 (JUVENILE TYPE)
EDTA2,2858,NEPHRONOPHTHISIS - TYPE 2 (INFANTILE TYPE)
EDTA2,2862,NEPHRONOPHTHISIS - TYPE 3 (ADOLESCENT TYPE)
EDTA2,2870,NEPHRONOPHTHISIS - TYPE 4 (JUVENILE TYPE)
EDTA2,2889,NEPHRONOPHTHISIS - TYPE 5
EDTA2,2891,NEPHRONOPHTHISIS - TYPE 6
EDTA2,2901,PRIMARY FANCONI SYNDROME
EDTA2,2917,TUBULAR DISORDER AS PART OF INHERITED METABOLIC DISEASES
EDTA2,2929,DENT DISEASE
EDTA2,2938,LOWE SYNDROME (OCULOCEREBRORENAL SYNDROME)
EDTA2,2940,INHERITED AMINOACIDURIA
EDTA2,2955,CYSTINURIA
EDTA2,2964,CYSTINOSIS
EDTA2,2972,INHERITED RENAL GLYCOSURIA
EDTA2,2986,HYPOPHOSPHATAEMIC RICKETS X-LINKED (XL)
EDTA2,2993,HYPOPHOSPHATAEMIC RICKETS AUTOSOMAL RECESSIVE (AR)
EDTA2,3000,PRIMARY RENAL TUBULAR ACIDOSIS (RTA)
EDTA2,3016,PROXIMAL RENAL TUBULAR ACIDOSIS (RTA) - TYPE II
EDTA2,3028,DISTAL RENAL TUBULAR ACIDOSIS (RTA) - TYPE I
EDTA2,3037,DISTAL RENAL TUBULAR ACIDOSIS WITH SENSORINEURAL DEAFNESS - GENE MUTATIONS
EDTA2,3044,NEPHROGENIC DIABETES INSIPIDUS
EDTA2,3059,LESCH NYHAN SYNDROME - HYPOXANTHINE GUANINE PHOSPHORIBOSYL TRANSFERASE DEFICIENCY
EDTA2,3063,PHOSPHORIBOSYL PYROPHOSPHATE SYNTHETASE (PRPPS) SUPERACTIVITY
EDTA2,3071,ALAGILLE SYNDROME
EDTA2,3085,BARTTER SYNDROME
EDTA2,3092,GITELMAN SYNDROME
EDTA2,3102,LIDDLE SYNDROME
EDTA2,3118,APPARENT MINERALOCORTICOID EXCESS
EDTA2,3125,GLUCOCORTICOID SUPPRESSIBLE HYPERALDOSTERONISM
EDTA2,3139,INHERITED / GENETIC DIABETES MELLITUS TYPE II
EDTA2,3141,PSEUDOHYPOALDOSTERONISM TYPE 1
EDTA2,3156,PSEUDOHYPOALDOSTERONISM TYPE 2 (GORDON SYNDROME)
EDTA2,3160,FAMILIAL HYPOCALCIURIC HYPERCALCAEMIA
EDTA2,3173,FAMILIAL HYPERCALCIURIC HYPOCALCAEMIA
EDTA2,3187,FAMILIAL HYPOMAGNESAEMIA
EDTA2,3194,PRIMARY HYPEROXALURIA
EDTA2,3207,PRIMARY HYPEROXALURIA TYPE I
EDTA2,3211,PRIMARY HYPEROXALURIA TYPE II
EDTA2,3224,FABRY DISEASE - NO HISTOLOGY
EDTA2,3230,FABRY DISEASE - HISTOLOGICALLY PROVEN
EDTA2,3248,XANTHINURIA
EDTA2,3253,NAIL-PATELLA SYNDROME
EDTA2,3269,RUBINSTEIN-TAYBI SYNDROME
EDTA2,3276,TUBEROUS SCLEROSIS
EDTA2,3282,VON HIPPEL-LINDAU DISEASE
EDTA2,3295,MEDULLARY SPONGE KIDNEYS
EDTA2,3305,HORSE-SHOE KIDNEY
EDTA2,3314,FRASIER SYNDROME
EDTA2,3322,BRANCHIO-OTO-RENAL SYNDROME
EDTA2,3333,WILLIAMS SYNDROME
EDTA2,3346,TOWNES-BROCKS SYNDROME
EDTA2,3351,LAWRENCE-MOON-BIEDL / BARDET-BIEDL SYNDROME
EDTA2,3367,MITOCHONDRIAL CYTOPATHY
EDTA2,3379,FAMILIAL NEPHROPATHY
EDTA2,3380,ACUTE KIDNEY INJURY
EDTA2,3398,ACUTE KIDNEY INJURY DUE TO HYPOVOLAEMIA
EDTA2,3403,ACUTE KIDNEY INJURY DUE TO CIRCULATORY FAILURE
EDTA2,3419,ACUTE KIDNEY INJURY DUE TO SEPSIS
EDTA2,3426,ACUTE KIDNEY INJURY DUE TO RHABDOMYOLYSIS
EDTA2,3435,ACUTE KIDNEY INJURY DUE TO NEPHROTOXICITY
EDTA2,3442,ACUTE CORTICAL NECROSIS
EDTA2,3457,ACUTE PYELONEPHRITIS
EDTA2,3461,KIDNEY TUMOUR
EDTA2,3474,RENAL CELL CARCINOMA - HISTOLOGICALLY PROVEN
EDTA2,3488,TRANSITIONAL CELL CARCINOMA - HISTOLOGICALLY PROVEN
EDTA2,3490,WILMS TUMOUR - HISTOLOGICALLY PROVEN
EDTA2,3501,MESOBLASTIC NEPHROMA - HISTOLOGICALLY PROVEN
EDTA2,3517,SINGLE KIDNEY IDENTIFIED IN ADULTHOOD
EDTA2,3529,CHRONIC KIDNEY DISEASE (CKD) / CHRONIC RENAL FAILURE (CRF) CAUSED BY TUMOUR NEPHRECTOMY
EDTA2,3538,CHRONIC KIDNEY DISEASE (CKD) / CHRONIC RENAL FAILURE (CRF) DUE TO TRAUMATIC LOSS OF KIDNEY
EDTA2,3540,CHRONIC KIDNEY DISEASE (CKD) / CHRONIC RENAL FAILURE (CRF) DUE TO DONOR NEPHRECTOMY
EDTA2,3555,CHRONIC KIDNEY DISEASE (CKD) / CHRONIC RENAL FAILURE (CRF) - AETIOLOGY UNCERTAIN / UNKNOWN - NO HISTOLOGY
EDTA2,3564,CHRONIC KIDNEY DISEASE (CKD) / CHRONIC RENAL FAILURE (CRF) - AETIOLOGY UNCERTAIN / UNKNOWN - HISTOLOGICALLY PROVEN
EDTA2,3572,HAEMATURIA AND PROTEINURIA - NO HISTOLOGY
EDTA2,3604,NEPHROTIC SYNDROME OF CHILDHOOD - STEROID RESISTANT - NO HISTOLOGY
EDTA2,3615,NEPHROTIC SYNDROME OF CHILDHOOD - NO TRIAL OF STEROIDS - NO HISTOLOGY
EDTA2,3627,RENAL CYSTS AND DIABETES SYNDROME
EDTA2,3636,CHRONIC URATE NEPHROPATHY - NO HISTOLOGY
EDTA2,3643,CHRONIC RENAL FAILURE DUE TO SYSTEMIC INFECTION
EDTA2,3658,RENAL COLOBOMA SYNDROME
EDTA2,3662,HYPERCALCAEMIC NEPHROPATHY
EDTA2,3670,RETROPERITONEAL FIBROSIS SECONDARY TO PERI-AORTITIS
EDTA2,3689,RETROPERITONEAL FIBROSIS SECONDARY TO DRUGS
EDTA2,3691,RENAL FAILURE
EDTA2,3708,CHRONIC RENAL FAILURE
EDTA2,3712,ISOLATED HAEMATURIA - NO HISTOLOGY
EDTA2,3720,ISOLATED PROTEINURIA - NO HISTOLOGY
EDTA2,3731,PRIMARY HYPEROXALURIA TYPE III
EDTA2,3749,GLOMERULONEPHRITIS - NO HISTOLOGY
